Abstract / Summary
Heterozygous carriers of autosomal recessive disease variants are often considered clinically unaffected, yet population biobanks can reveal measurable carrier phenotypes. MMACHC (MIM: 609831) encodes an intracellular cobalamin-processing protein. Bi-allelic MMACHC loss causes cobalamin C (cblC) disease, with methylmalonic acid (MMA) and homocysteine (Hcy) accumulation. Because Mmachc heterozygous mice show elevated MMA and Hcy,1 we asked whether MMACHC heterozygosity leaves a detectable biochemical signature in humans.
Topics
Primary Source
The American Journal of Human Genetics